FXA · Stage, GEX levels and seasonality
FXA
Last close $68.87 (-0.12%) on 2026-10-08
No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.
Open the chartWeinstein stage
Stage 3B — Topping · 1 weeks in this stage · 30-week average $69.97
Stage 3 (topping): the advance stalls and the 30-week average flattens.
What would change it: Stage 4 begins on a weekly close below 68.36 (the top's support) under a flat or falling 30-week SMA.
GEX levels
| Put wall | Gamma flip | Call wall |
|---|---|---|
| 68 | 69.91 | 73 |
Set before the open on 2026-10-02. Members see today's levels, updated every 15 minutes. How to read GEX.
Seasonality
| Month | Average return | Months up | Years |
|---|---|---|---|
| January | +0.33% | 75% | 4 |
| February | 0% | 50% | 4 |
| March | -1.75% | 0% | 4 |
| April | +2.82% | 75% | 4 |
| May | +0.13% | 50% | 4 |
| June | -0.21% | 75% | 4 |
| July | -0.98% | 25% | 4 |
| August | +1.51% | 75% | 4 |
| September | -0.64% | 50% | 4 |
| October (this month) | -1.1% | 33% | 3 |
| November | +0.73% | 67% | 3 |
| December | -0.11% | 67% | 3 |
Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.
On Signa plans
The Signa score and Action Card for FXA, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.
No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.
Questions about FXA
What Weinstein stage is FXA in?
FXA is in Stage 3B — Topping, for 1 weeks, based on completed weekly bars and its 30-week moving average (69.97).
How has FXA done in October?
Over the last 3 years, FXA averaged -1.1% in October and rose in 33% of them. Past seasonality does not predict future returns.
What are FXA's GEX levels?
Before the open on 2026-10-02, FXA's put wall was 68, gamma flip 69.91 and call wall 73. Signa members see today's levels, updated every 15 minutes.
Educational content only, not financial advice. Trading involves substantial risk.